期刊文献+

高频超声对甲状腺乳头状微小癌的诊断价值 被引量:8

The diagnostic value of high frequency ultrasound PTMC
下载PDF
导出
摘要 目的分析甲状腺乳头状微小癌(PTMC)的超声声像图特点,以提高PTMC的术前超声检出率。方法回顾性分析经手术病理证实的46例(46个)PTMC病灶的超声二维声像图表现,并以同期51例(51个)直径≤1.0cm的NG结节作为对照组对比分析。结果 PTMC与NG结节在形态、边界、纵横比、内部回声、微小钙化、囊性变等方面差异有统计学意义(P<0.01)。结论高频超声对诊断PTMC及术前评估有重要价值。PTMC具有与NG结节不同的声像图特点,PTMC的灰阶超声特点为形态不规则、低回声、边界模糊、有微小钙化、无囊性变。对NG患者,重点观察≤1cm的低回声结节,以及早发现PTMC,并且常规扫查中央区淋巴结,尤其对高度怀疑多灶性的PTMC患者或者甲状腺外浸润者,更要仔细扫查。 Objective To analyze the sonographic appearance of papillary microcarcinoma of the thyroid (PTMC), and to increase the preoperative detection rate of PTMC. Methods The ultrasonographic features of 46 cases (46 nod- ules) of PTMC were analyzed compared with the result of 51 cases (51 nodules ) of nodular goiter (NG)≤1cm in the same period. Results There was statistical difference in shape, boundary, echo intensity, microealcification, cystic degeneration between PTMC and NG (P 〈 0.01 ). Conclusion High frequency ultrasound in the diagnosis of PTMC and preoperative assessment has important value, PTMC has different sonographic features from NG nodules. PTMC shows form irregular,low-echo, boundary fuzzy ,small calcification, no halo or cystic degeneration on gray-scale ultrasound images. Observing the low level echo nodule which is ≤1cm in diameter will be helpful to detect PTMC early, and scan level Ⅵ lymph nodes routinely, muhifocality and extra-thyroidal invasion should be scaned more carefully.
作者 洪杰 姜玉新
出处 《中国现代医生》 2013年第18期78-80,F0003,共4页 China Modern Doctor
基金 国家自然科学基金(81171354)
关键词 PTMC(甲状腺乳头状微小癌) NG(结节性甲状腺肿) 超声二维声像图 中央区淋巴结 Papillary microcarcinoma of the thyroid (PTMC) Nodular goiter (NG) Two-dimensional uhrasono- graphic Central compartment lymph node
  • 相关文献

参考文献23

  • 1Stewart BW,KIeihues P. World Cancer Report IARC Press:Lyon.2003.
  • 2张丽华,孙荣超,陈瑛.甲状腺癌的临床病理分析[J].临床肿瘤学杂志,2003,8(2):121-122. 被引量:19
  • 3Piersanti M, Ezzat S,Asa SL. Controversies in papillary microcarcino-ma of the thyroid[J]. Endocr Pathol,2003,14(3) : 183-191.
  • 4Randolph GW. Follicular carcinoma of the thyroid. Saunders :Philadelphia,2003 : 312-333.
  • 5Pelizzo MR,Boschin IM,Toniato A,et al. Natural history,diagnosis,treatment and outcome of papillary thyroid microcarcinoma (PTMC) : amono-institutional 12-year experience[J]. Nucl MedCommun, 2004,25?6):547-552.
  • 6褚洁,杨丽春.甲状腺微小乳头状癌的超声诊断及进展[J].中国医学影像技术,2010,26(10):1996-1998. 被引量:30
  • 7江昌新,谭郁彬.内分泌器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:154-186.
  • 8Fink A,Tomlinson G,Freeman JL,el al. Occult micropapillary carci-noma associated with benign follicular thyroid disease and unrelatedthyroid neoplasms[J]. Mod Pathol, 1996,9(8):816-820.
  • 9Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinomaof the thyroid. A “normal ” finding in Finland. A systematic autopsystudy[J]. Cancer,1985,56(3) :531-538.
  • 10Yamamoto Y, Maeda T, lzumi K,et al. Occult papillary carcinoma ofthe thyroid. A study of 408 autopsy casesfj]. Cancer,65 : 1173-1179.

二级参考文献56

共引文献223

同被引文献94

  • 1杨腾飞,王家东.影像学检查在甲状腺癌诊断中的临床意义[J].国外医学(肿瘤学分册),2005,32(12):921-923. 被引量:6
  • 2Hughes DT, Haymart MR, Miller BS, et al. The most commonly occurring papillary thyroid cancer in the United States is now ami- crocarcinoma in a patient older than 45 years [ J ]. Thyroid,2011, 21 (3) :231-236.
  • 3Elio R, Ettore CU, Malta B, et al. Thyroid papillary microcarei- noma a descriptive and recta-analysis study [ J ]. Eur J Endoc, 2008,159 (6) :659-673.
  • 4邢壮杰,李旭,赵晖,等.甲状腺癌诊断中CT与B超价值的比较与探讨[J].中国医药,2013,8(z1):29-30.
  • 5Jun P, Chow LC, Jeffrey RB. The sonographic features of papillary thyroid carcinomas: pictorial essay[ J]. Ultrasound Q, 2005, 21 (1) : 39-45.
  • 6Ofija IB, Hamrahian AH, Reddy SS. Management of nondiagnostic thyroid fine-needle aspiration biopsy : survey of endocrinologists [ J ]. Endocr Pract, 2004, 10(4): 317-323.
  • 7Alexander EK, Heefing JP, Benson CB, et al. Assessment of non- diagnostic ultrasound-guided fine needle aspirations of thyroid nod- ules[ J]. J Clin Endocrinol Metab, 2002, 87(11) : 4924-4927.
  • 8Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term re- sults of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma [ J ]. J Clin Endocrinol Metab, 1986, 63(4): 960-967.
  • 9Feine U, Lietzenmayar R, Hanke JP, et al. 18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I [ Article in German] [ J]. Nuklearmedizin, 1995, 34(4) : 127-134.
  • 10Filesi M, Signore A, Ventroni G, et al. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases[J]. J Nuel Med, 1998, 39(9) : 1542-1546.

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部